HealthDay News — The American Academy of Pediatrics (AAP) is suing the US Department of Health and Human Services (HHS), seeking to stop nearly $12 million in federal funding cuts that it says put ...

In a landmark legal settlement approved last week, Aetna agreed to cover fertility treatments for same-sex couples the same way it does for heterosexual couples. The deal applies nationwide and is ...

The researchers found that 6.5% of adults experienced cost burdens and 3.5% had CCBs during year one; 17.4% and 9.9%, respectively, experienced these outcomes at least once over 4 years. Overall, 24.7 ...

Receipt of educational leaflet also reduces misperception of asymptomatic bacteriuria as urinary tract infection.

Setrusumab is a monoclonal antibody that inhibits sclerostin, a protein that negatively regulates bone development, allowing for new bone formation.

The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...

Adults with congenital heart disease benefit from routine care at ACHD centers and collaboration with ACHD cardiologists ...

Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.

Diagnostic evaluation should follow principle of 'as low as reasonably achievable'; systemic therapy should be deferred until second trimester ...

In modified intention-to-treat analysis, time to linkage to care significantly less for people with HIV in intervention group ...

Wegovy tablets are expected to be available in early January 2026. The Food and Drug Administration (FDA) has approved Wegovy ® (semaglutide) tablets, the first oral glucagon-like peptide-1 (GLP-1) ...